David Solomon
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von David Solomon
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
26
| Public Company | Biotechnology | 26 |
| Public Company | Pharmaceuticals: Major | 21 | |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.
17
| Extinct | Pharmaceuticals: Other | 17 |
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Miscellaneous Commercial Services | 11 | |
| Public Company | Pharmaceuticals: Generic | 8 | |
Weill Cornell Medical College
5
| College/University | Other Consumer Services | 5 |
| Public Company | Biotechnology | 4 | |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA.
2
| Holding Company | Medical Specialties | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Solomon
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Founder | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer President Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| TRANSGENE | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Aarhus | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| ABLYNX | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COMPASS PATHWAYS PLC | Biotechnology | Director of Finance/CFO Director/Board Member | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree Masters Business Admin | |
| CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SAREUM HOLDINGS PLC | Miscellaneous | Chairman Director/Board Member | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| King's College London | College/University | Undergraduate Degree Doctorate Degree | |
| TDC A/S | Major Telecommunications | Corporate Officer/Principal Corporate Officer/Principal | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Chairman Comptroller/Controller/Auditor | |
| E-THERAPEUTICS PLC | Biotechnology | Chairman Chief Operating Officer | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| University of Liege | College/University | Corporate Officer/Principal Graduate Degree | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 15 |
| Frankreich | 14 |
| Dänemark | 8 |
| Vereinigte Staaten | 7 |
| Schweiz | 5 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 2 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 620 |
| Chairman | 223 |
| Corporate Officer/Principal | 221 |
| Independent Dir/Board Member | 153 |
| Chief Executive Officer | 113 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Philippe Pouletty | 51 |
| Andrew Richards | 44 |
| Iain Ross | 41 |
| Jerome Zeldis | 38 |
| Stephen Parker | 34 |
| Hugo Brugière | 33 |
| Russell Greig | 31 |
| Alf Gunnar Martin Nicklasson | 31 |
| Catherine Moukheibir | 29 |
| James Ede-Golightly | 29 |
| Michel de Rosen | 28 |
| Benedicte Fossum | 27 |
| Lawrence Steinman | 26 |
| Anker Gunvald Lundemose | 25 |
- Börse
- Insiders
- David Solomon
- Unternehmensverbindungen